从临床和基本的角度来看,口腔性粘膜炎治疗的最新进展
Kentaro Ono1, Takao Ueno2, Mizuho A Kido3
1Division of Physiology, Kyushu Dental University, Fukuoka, Japan.
Journal of oral biosciences
|June 12, 2024
概括
癌症患者的口腔性粘膜炎 (OUM) 管理需要更好的治疗方法. 对瞬态受体潜能 (TRP) 通道的研究为愈合和缓解疼痛提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 口腔医学是指口腔医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 口腔性粘膜炎 (OUM) 经常影响癌症患者,特别是那些接受化学辐射治疗的人.
- 有效的OUM管理对于不间断的癌症治疗和患者舒适性至关重要.
- 最近的研究加深了对OUM原因的理解,推动了新的治疗开发.
研究的目的:
- 对口腔性粘膜炎 (OUM) 的当前治疗策略进行审查.
- 探索了解OUM粘膜愈合和疼痛机制的最新进展.
- 以突出基于分子研究的新型治疗目标.
主要方法:
- 对当代OUM治疗方法的文献综述.
- 对粘膜层愈合和疼痛背后的分子机制的分析.
- 对新型治疗剂的临床试验数据的检查.
主要成果:
- 目前的OUM管理包括口腔卫生,辐射节约技术和局部止痛药.
- 现有的治疗方法有局限性,这强调了需要更有效的疗法.
- 对瞬态受体潜能 (TRP) 通道的分子研究为OUM机制提供了洞察力.
结论:
- 向TRPV3和TRPV4可能会促进重新上皮质化和增强伤口愈合.
- 抑制TRPV1,TRPA1和TRPV4可以缓解OUM引起的疼痛.
- 合作研究对于开发创新的OUM疗法至关重要.
相关概念视频
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
445
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
445
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
408
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
408
Peptic Ulcer Disease V: Surgical Management and Nursing Care
288
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
288
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
378
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
378
Peptic Ulcer Disease I: Introduction
163
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
163


